Drugs in R&D
Drugs in R&D was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.
The journal publishes original research and reviews on drugs from all phases of drug development and clinical use following approval.
Manuscripts submitted to the journal for publication will be subject to a $3,000 article processing charge (APC) upon acceptance. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.
Risk Evaluation and Mitigation Strategies (REMSs): Are They Improving Drug Safety? A Critical Review of REMSs Requiring Elements to Assure Safe Use (ETASU)
Pol F. Boudes (February 2017)
Original Research Article
Therapy in Practice
To view the rest of this content please follow the download PDF link above.